Wenjing Zhao

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Reversible Heat-Set Organogel Based on Supramolecular Interactions of β-Cyclodextrin in <i>N</i>,<i>N</i>-Dimethylformamide

Yuanyuan Li, Jian Liu, Guangyan Du et al. · The Journal of Physical Chemistry B · 2010 · 65 citations

Natural Sciences, Chemistry, Materials Science +17

Salvianolic Acid B Improves Mitochondrial Function in 3T3-L1 Adipocytes Through a Pathway Involving PPARγ Coactivator-1α (PGC-1α)

Yanyun Pan, Wenjing Zhao, Dandan Zhao et al. · Frontiers in Pharmacology · 2018 · 54 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et al. · Diabetes Care · 2022 · 35 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17